Search - tctmd.com

Displaying 421 - 440 of 5273

Sort: Relevancy | Date

News Daily News

Satisfaction With Life Portends Less CVD: UK Biobank Analysis

Caitlin E. Cox

September 20, 2024

News Daily News

MI Care Varies Across Asian Subgroups in the US

Yael L. Maxwell

September 19, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Conference News ESC 2024

Endometriosis and CV Risk: Link Needs Further Attention and Research

Yael L. Maxwell

September 12, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Conference News ESC 2024

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

Yael L. Maxwell

September 04, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Conference News ESC 2024

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

Todd Neale

September 02, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

Todd Neale

August 30, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

Advertisement

Satisfaction With Life Portends Less CVD: UK Biobank Analysis

MI Care Varies Across Asian Subgroups in the US

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Endometriosis and CV Risk: Link Needs Further Attention and Research

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Statins Are Cost-effective in the Elderly

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

September 2024 Dispatch for the CV Team

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Polypills Show Promise in Diverse Hypertensive Patient Groups

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content